Media Inquiries
iCAD, Inc.
603.882.5200
pr@icadmed.com
From the Newsroom
May 18, 2022
New Real-World Evidence Shows ProFound AI Improves Cancer Detection and Accuracy with Digital Breast Tomosynthesis, or 3D MammographyMay 16, 2022
New Research Finds iCAD's ProFound AI Risk for Digital Breast Tomosynthesis is 2.4x More Accurate than Traditional Lifetime Risk ModelsMay 12, 2022
iCAD to Present at the Spring Into Action – Best Ideas Virtual Investor Conference on May 17th, 2022May 11, 2022
iCAD Reports Financial Results for First Quarter Ended March 31, 2022April 28, 2022
iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Clinical and IT Experts from Wake Radiology
» View all news »
What's Trending
Explore the Latest Information from iCAD
Press ReleasesLearn More>EventsLearn More>iNFORMED BlogLearn More>Media CoverageLearn More>InvestorsLearn More>Clinical Case StudiesLearn More>Customer TestimonialsLearn More>
Stay Connected
Follow us on social media to stay connected and informed on all the latest iCAD news, events and product announcements.
CONTACT US
Products
ProFound AI Risk
ProFound AI for Digital Breast Tomosynthesis
ProFound AI Solutions - EU
ProFound AI Solutions - FR
PowerLook Density Assessment
SecondLook for 2D Mammography
VeraLook Colon Polyp Detection
Resources
ProFound Institute
Educational Webinars
Customer Case Studies
Customer Testimonials
Patient Resources
Compliance
Training & Support
EU Customer Portal
Precise and Powerful Healthcare Solutions
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.